Within the context of the MyGenom Project, MGVI-NIBM specifically is taking on the responsibilities of:
As a co-partner in the MyGenom Project, the NIH plays a key role in participant recruitment across Malaysia, with designated recruitment centres established nationwide. Leveraging its expertise in biomedical and clinical research, the NIH can thoroughly screen both healthy and non-healthy Malaysians who contribute to the project, as the goal in MyGenom Phase I is to sequence the genomes of healthy individuals to establish a reference genomic baseline for the Malaysian population. Participant screening by the NIH includes health assessments, physical and blood tests, and securing informed consent. Furthermore, the NIH is responsible for preparing and maintaining blood samples at the highest standards of quality and safety until they are transferred to MGVI for sequencing. Downstream correlation between genotypes (genetic information) and phenotypes (physical manifestations) post-sequencing will be a joint effort between NIH and MGVI-NIBM.
Biobank Unit aims to promote and support high-quality biomedical research within the Ministry of Health (MOH) by overseeing the MOH Biobank. This facility is dedicated to the collection of various types of biological samples, including blood, fresh tissue, saliva, and formalin-fixed tissue, along with related anonymized data from donors who have provided informed consent for their samples and data to be used in ethically approved future research.
Objectives
Activities
o Liaise with clinicians, researchers & administrators
o Work-flow for consent; sample acquisition and logistics
o Manage and coordinate sample / data requests from researchers